Literature DB >> 28007995

Corticosteroids compromise survival in glioblastoma in part through their elevation of blood glucose levels.

Rainer J Klement1, Colin E Champ2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28007995     DOI： 10.1093/brain/aww324

Source DB:  PubMed          Journal:  Brain        ISSN： 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  12 in total

1.  Provocative Question: Should Ketogenic Metabolic Therapy Become the Standard of Care for Glioblastoma?

Authors:  Thomas N Seyfried; Laura Shelton; Gabriel Arismendi-Morillo; Miriam Kalamian; Ahmed Elsakka; Joseph Maroon; Purna Mukherjee
Journal:  Neurochem Res       Date:  2019-04-25       Impact factor: 3.996

2.  [Corticosteroids compromise survival in glioblastoma patients after radio- and chemotherapy].

Authors:  Clemens Seidel; Rolf-Dieter Kortmann
Journal:  Strahlenther Onkol       Date:  2017-11       Impact factor: 3.621

Review 3.  Beneficial effects of ketogenic diets for cancer patients: a realist review with focus on evidence and confirmation.

Authors:  Rainer J Klement
Journal:  Med Oncol       Date:  2017-06-26       Impact factor: 3.064

4.  Management of Glioblastoma Multiforme in a Patient Treated With Ketogenic Metabolic Therapy and Modified Standard of Care: A 24-Month Follow-Up.

Authors:  Ahmed M A Elsakka; Mohamed Abdel Bary; Eman Abdelzaher; Mostafa Elnaggar; Miriam Kalamian; Purna Mukherjee; Thomas N Seyfried
Journal:  Front Nutr       Date:  2018-03-29

Review 5.  Review of Natural Product-Derived Compounds as Potent Antiglioblastoma Drugs.

Authors:  Moon Nyeo Park; Hyo Sook Song; Myungsun Kim; Min-Jung Lee; Whisung Cho; Hyun-Jin Lee; Cho-Hyun Hwang; Soojong Kim; Yechae Hwang; Beomku Kang; Bonglee Kim
Journal:  Biomed Res Int       Date:  2017-10-18       Impact factor: 3.411

Review 6.  Sialic Acid-Siglec Axis as Molecular Checkpoints Targeting of Immune System: Smart Players in Pathology and Conventional Therapy.

Authors:  Przemyslaw Wielgat; Karol Rogowski; Katarzyna Niemirowicz-Laskowska; Halina Car
Journal:  Int J Mol Sci       Date:  2020-06-19       Impact factor: 5.923

Review 7.  Cell-based immunotherapy of glioblastoma multiforme.

Authors:  Igor Bryukhovetskiy
Journal:  Oncol Lett       Date:  2022-02-23       Impact factor: 2.967

8.  The Impact of Serum Glucose, Anti-Diabetic Agents, and Statin Usage in Non-small Cell Lung Cancer Patients Treated With Definitive Chemoradiation.

Authors:  Nick A Iarrobino; Beant S Gill; Mark Bernard; Rainer J Klement; Maria Werner-Wasik; Colin E Champ
Journal:  Front Oncol       Date:  2018-07-27       Impact factor: 6.244

9.  Accelerated hyperfractionated radiochemotherapy with temozolomide is equivalent to normofractionated radiochemotherapy in a retrospective analysis of patients with glioblastoma.

Authors:  Victor Lewitzki; Rainer J Klement; Rebekka Kosmala; Dominik Lisowski; Michael Flentje; Bülent Polat
Journal:  Radiat Oncol       Date:  2019-12-12       Impact factor: 3.481

10.  Dexamethasone premedication suppresses vaccine-induced immune responses against cancer.

Authors:  Mathias Vormehr; Sophie Lehar; Lena M Kranz; Siri Tahtinen; Yoko Oei; Vincent Javinal; Lélia Delamarre; Kerstin C Walzer; Mustafa Diken; Sebastian Kreiter; Ira Mellman; Ugur Sahin; Jill M Schartner; Özlem Türeci
Journal:  Oncoimmunology       Date:  2020-05-13       Impact factor: 8.110
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.